iX Biopharma Ltd. Financial Overview
iX Biopharma Ltd.'s market cap is currently S$120.71M. The company's EPS TTM is S$-0.004; its P/E ratio is -10.52; iX Biopharma Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
